PASG Passage Bio Corp: Quarterly EPS earnings growth
Passage Bio, Inc. (PASG) utilizes external bio-factories to create vectors, thereby minimizing technical failures. However, a narrow niche and the risk of side effects leave the model vulnerable. An ethical approach to CNS treatment has secured the company support from specialized investors. The current value is 39.30, which clearly demonstrates the relative growth of quarterly EPS on this chart.
%20Net%20earnings%20per%20share%20growth%20for%20the%20trailing%20year&width=1200&height=400&colorIndex=0&v=mwbxec28.yq-7cu2wow&start=20220704&end=20261111&filename=GURU_Markets_-_PASG_-_Passage-Bio-Inc._-_Net-earnings-per-share-growth-for-the-trailing-year "Quarterly EPS earnings growth: Passage Bio Corp (PASG) for 07/04/2022 - 11/11/2026 | 👁️GURU.Markets👁️")
Financial and market metric breakdowns for Passage Bio, Inc. (PASG)
- share price and expert price forecast:
- company stock capitalization data:
- balance sheet net asset value indicators:
- issuer credit burden and liquidity indicators:
- earnings and valuation multiples indicators:
PASG - Net Financial Result|Expected Profit Passage Bio, Inc.|PASG - Price to Earnings Multiple|Forward P/E Multiple passagebio.com|PASG - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Passage Bio Corp|PASG - Operating income before deduction of amortization|Earnings per share for the last twelve months Passage Bio|PASG - Earnings per one share for the last 12 months|Quarterly EPS earnings growth passagebio.com|PASG - Earnings growth in current year|Net earnings per share growth forecast for next year Passage Bio, Inc.
Analysis of all company metrics:Passage Bio, Inc.
Quarterly earnings per share dynamics measure the rate of change in net income, allowing for an assessment of the resilience of capital returns against inflationary risks and market shocks. By analyzing the amplitude of quarterly EPS fluctuations, an investor can correlate financial volatility with the expenditures of Passage Bio, Inc. (PASG) on the development of innovative gene therapy methods for the correction of neurological pathologies during its active growth phase.
Analysis of competing companies
BIIB: Quarterly EPS earnings growth|Neurocrine (NBIX) - Quarterly EPS earnings growth|RGC (Regencell) - Quarterly EPS earnings growth|AXSM - Net earnings per share growth for the trailing year|Quarterly EPS earnings growth ACAD|XENE - Earnings per share growth in annualized terms for the last twelve months|Viking Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months SUPN|Catalyst Pharmaceuticals Inc - Quarterly EPS earnings growth|DNLI: Year-over-year earnings per share growth for the last twelve months|HRMY: Quarterly EPS earnings growth|BHVN - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Amylyx Pharmaceuticals, Inc.|Earnings per share growth in annualized terms for the last twelve months Trevi Therapeutics Inc TRVI|Year-over-year net earnings per share growth for the last 12 months PRAX (Praxis Medicines)|AVXL (Anavex Life Sciences Corp) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth CBLL (CeriBell, Inc.)|Year-over-year net earnings per share change for the last twelve months prothena.com (PRTA)|ALEC - Year-over-year earnings per share growth for the last twelve months|ANNX (Annexon Biosciences) - Year-over-year earnings per share growth for the last 12 months|OMER: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Neurogene Therapeutics|Year-over-year net earnings per share growth for the last 12 months ACIU|voyagertherapeutics.com (VYGR) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Neumora Therapeutics, Inc. (NMRA)|SCLX: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth TVGN (Tevogen Bio Holdings, Inc.)|Quarterly EPS earnings growth Alpha Cognition Inc ACOG|CGTX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months inhibikase.com IKT|SAVA: Quarterly EPS earnings growth|Net earnings per share growth for the trailing year Assertio ASRT|Year-over-year earnings per share growth for the last twelve months Coya Therapeutics Inc|Year-over-year earnings per share growth for the last 12 months VTGN (VistaGen Therapeutics Inc)|Quarterly EPS earnings growth OVID|ABOS - Earnings per share growth in annualized terms for the last twelve months|CervoMed - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Alterity Therapeutics Ltd. ATHE|CLNN - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months PEPG (PepGen Inc.)|Jupiter Neurosciences (JUNS) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months relmada.com (RLMD)|Year-over-year earnings per share growth for the last twelve months Annovis Bio|Grace Tx - Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth AIFF|Quarterly EPS earnings growth anewmeds.com (KLTO)|Year-over-year earnings per share growth for the last twelve months NeuroSense Therapeutics Ltd. NRSN|Year-over-year net earnings per share change for the last twelve months revivapharma.com (RVPH)|MTVA - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months NeurAxis Inc. NRXS|HSDT: Quarterly EPS earnings growth|Neuphoria Therapeutics (NEUP) - Quarterly EPS earnings growth|NERV (Minerva Neurosciences) - Quarterly EPS earnings growth|ATHA - Net earnings per share growth for the trailing year|Quarterly EPS earnings growth ADXN|ALZN - Earnings per share growth in annualized terms for the last twelve months|Cyclerion Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PTIX|Pasithea - Quarterly EPS earnings growth|CRGT: Year-over-year earnings per share growth for the last twelve months|ATXI: Quarterly EPS earnings growth|BCLI - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Cara Therapeutics, Inc|Earnings per share growth in annualized terms for the last twelve months Chromocell CHRO|Year-over-year net earnings per share growth for the last 12 months ELYM (Eliem Therapeutics)|ITCI (intracellulartherapies.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth LBPH (Longboard Pharmaceuticals, Inc.)|Year-over-year net earnings per share change for the last twelve months Marinus Pharmaceuticals Inc (MRNS)|NKGN - Year-over-year earnings per share growth for the last twelve months|NRBO (NeuroBo Pharma) - Year-over-year earnings per share growth for the last 12 months|SAGE: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months synaptogen.com|Year-over-year net earnings per share growth for the last 12 months TRVN|Vigil Neuro (VIGL) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Anew Medical, Inc. (WENA)|CERE: Year-over-year net earnings per share trend for the last twelve months
